Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Highly Variable Sialylation Status of Donor-Specific Antibodies Does Not Impact Humoral Rejection Outcomes.

Barba T, Harb J, Ducreux S, Koenig A, Mathias V, Rabeyrin M, Pouliquen E, Sicard A, Chartoire D, Dugast E, Defrance T, Morelon E, Brouard S, Dubois V, Thaunat O.

Front Immunol. 2019 Mar 20;10:513. doi: 10.3389/fimmu.2019.00513. eCollection 2019.

2.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
3.

Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic Immunosuppression.

Dahdal S, Saison C, Valette M, Bachy E, Pallet N, Lina B, Koenig A, Monneret G, Defrance T, Morelon E, Thaunat O.

Front Immunol. 2019 Feb 5;9:3178. doi: 10.3389/fimmu.2018.03178. eCollection 2018.

4.

Pregnancy and donor-specific HLA-antibody-mediated rejection after liver transplantation: "Liaisons dangereuses"?

Dumortier J, Dedic T, Erard-Poinsot D, Rivet C, Guillaud O, Chambon-Augoyard C, Bosch A, Lachaux A, Couchonnal E, Thaunat O, Boillot O, Dubois V.

Transpl Immunol. 2019 Jun;54:47-51. doi: 10.1016/j.trim.2019.02.002. Epub 2019 Feb 8.

PMID:
30743001
5.

Infections after upper extremity allotransplantation: a worldwide population cohort study, 1998-2017.

Conrad A, Petruzzo P, Kanitakis J, Gazarian A, Badet L, Thaunat O, Vanhems P, Buron F, Morelon E, Sicard A; DIVAT consortium and the IRHCTT teams.

Transpl Int. 2019 Jan 11. doi: 10.1111/tri.13399. [Epub ahead of print]

PMID:
30633815
6.

Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.

Yazdani S, Callemeyn J, Gazut S, Lerut E, de Loor H, Wevers M, Heylen L, Saison C, Koenig A, Thaunat O, Thorrez L, Kuypers D, Sprangers B, Noël LH, Van Lommel L, Schuit F, Essig M, Gwinner W, Anglicheau D, Marquet P, Naesens M.

Kidney Int. 2019 Jan;95(1):188-198. doi: 10.1016/j.kint.2018.08.027. Epub 2018 Nov 3.

7.

Performances of creatinine-based glomerular filtration rate estimating equations in simultaneous pancreas-kidney transplant recipients: a single center cohort study.

Dantec A, Selistre L, Lemoine S, Buron F, de Souza VC, Rimmelé T, Thaunat O, Badet L, Morelon E, Dubourg L, Sicard A.

Transpl Int. 2019 Jan;32(1):75-83. doi: 10.1111/tri.13333. Epub 2018 Sep 19.

PMID:
30118552
8.

The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft loss.

Courant M, Visentin J, Linares G, Dubois V, Lepreux S, Guidicelli G, Thaunat O, Merville P, Couzi L, Taupin JL.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1872. doi: 10.1093/ndt/gfy182. No abstract available.

PMID:
29897514
9.

SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production.

Roders N, Herr F, Ambroise G, Thaunat O, Portier A, Vazquez A, Durrbach A.

Front Immunol. 2018 Apr 24;9:787. doi: 10.3389/fimmu.2018.00787. eCollection 2018.

10.

The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft loss.

Courant M, Visentin J, Linares G, Dubois V, Lepreux S, Guidicelli G, Thaunat O, Merville P, Couzi L, Taupin JL.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1853-1863. doi: 10.1093/ndt/gfy088.

PMID:
29672702
11.

CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.

Chen CC, Koenig A, Saison C, Dahdal S, Rigault G, Barba T, Taillardet M, Chartoire D, Ovize M, Morelon E, Defrance T, Thaunat O.

Front Immunol. 2018 Feb 19;9:275. doi: 10.3389/fimmu.2018.00275. eCollection 2018.

12.

Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection.

Chen CC, Pouliquen E, Broisat A, Andreata F, Racapé M, Bruneval P, Kessler L, Ahmadi M, Bacot S, Saison-Delaplace C, Marcaud M, Van Huyen JD, Loupy A, Villard J, Demuylder-Mischler S, Berney T, Morelon E, Tsai MK, Kolopp-Sarda MN, Koenig A, Mathias V, Ducreux S, Ghezzi C, Dubois V, Nicoletti A, Defrance T, Thaunat O.

J Clin Invest. 2018 Jan 2;128(1):219-232. doi: 10.1172/JCI93542. Epub 2017 Nov 20.

13.

High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors.

Marçais A, Marotel M, Degouve S, Koenig A, Fauteux-Daniel S, Drouillard A, Schlums H, Viel S, Besson L, Allatif O, Bléry M, Vivier E, Bryceson Y, Thaunat O, Walzer T.

Elife. 2017 Sep 6;6. pii: e26423. doi: 10.7554/eLife.26423.

14.

Mechanisms underlying human genetic diversity: consequence for antigraft antibody responses.

Reindl-Schwaighofer R, Heinzel A, Signorini L, Thaunat O, Oberbauer R.

Transpl Int. 2018 Mar;31(3):239-250. doi: 10.1111/tri.13059. Epub 2017 Sep 28. Review.

15.

A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.

Caillard S, Cellot E, Dantal J, Thaunat O, Provot F, Janbon B, Buchler M, Anglicheau D, Merville P, Lang P, Frimat L, Colosio C, Alamartine E, Kamar N, Heng AE, Durrbach A, Moal V, Rivalan J, Etienne I, Peraldi MN, Moreau A, Moulin B; French PTLD Registry.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1663-1670. doi: 10.2215/CJN.03790417. Epub 2017 Aug 17.

16.

Hypothermic pulsatile preservation of kidneys from uncontrolled deceased donors after cardiac arrest - a retrospective study.

Matillon X, Danjou F, Petruzzo P, Thaunat O, Rimmele T, Delsuc C, Faure A, Rabeyrin M, Meas Yedid V, Hanf W, Morelon E, Badet L, Codas R.

Transpl Int. 2017 Dec;30(12):1284-1291. doi: 10.1111/tri.13024. Epub 2017 Sep 12.

17.

Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national French survey study.

Normand G, Brunner F, Badet L, Buron F, Catton M, Massardier J, Esposito L, Grimbert P, Mourad G, Serre JE, Caillard S, Karam G, Cantarovich D, Morelon E, Thaunat O.

Transpl Int. 2017 Sep;30(9):893-902. doi: 10.1111/tri.12983. Epub 2017 Jun 15.

18.

mTOR inhibitors and risk of chronic antibody-mediated rejection after kidney transplantation: where are we now?

Grimbert P, Thaunat O.

Transpl Int. 2017 Jul;30(7):647-657. doi: 10.1111/tri.12975. Review.

19.

Cum hoc sed non propter hoc.

Chen CC, Pouliquen E, Kessler L, Dubois V, Thaunat O.

Am J Transplant. 2017 Jul;17(7):1960-1961. doi: 10.1111/ajt.14288. Epub 2017 May 3. No abstract available.

20.

Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.

Sicard A, Meas-Yedid V, Rabeyrin M, Koenig A, Ducreux S, Dijoud F, Hervieu V, Badet L, Morelon E, Olivo-Marin JC, Dubois V, Thaunat O.

Kidney Int. 2017 Jul;92(1):214-226. doi: 10.1016/j.kint.2017.01.011. Epub 2017 Mar 18.

PMID:
28318622
21.

Face Transplantation: Partial Graft Loss of the First Case 10 Years Later.

Morelon E, Petruzzo P, Kanitakis J, Dakpé S, Thaunat O, Dubois V, Choukroun G, Testelin S, Dubernard JM, Badet L, Devauchelle B.

Am J Transplant. 2017 Jul;17(7):1935-1940. doi: 10.1111/ajt.14218. Epub 2017 Mar 9.

22.

Lymphoid Neogenesis and Tertiary Lymphoid Organs in Transplanted Organs.

Koenig A, Thaunat O.

Front Immunol. 2016 Dec 27;7:646. doi: 10.3389/fimmu.2016.00646. eCollection 2016. Review.

23.

How to Escape the Immune Response: What Tumors Teach to Transplant Physicians/Immunologists.

Claisse G, Thaunat O, Mousson C, Wood KJ, Rifle G, Mariat C.

Transplantation. 2017 Dec;101(12):2825-2829. doi: 10.1097/TP.0000000000001639. Review.

PMID:
28072758
24.

Mature IgM-expressing plasma cells sense antigen and develop competence for cytokine production upon antigenic challenge.

Blanc P, Moro-Sibilot L, Barthly L, Jagot F, This S, de Bernard S, Buffat L, Dussurgey S, Colisson R, Hobeika E, Fest T, Taillardet M, Thaunat O, Sicard A, Mondière P, Genestier L, Nutt SL, Defrance T.

Nat Commun. 2016 Dec 7;7:13600. doi: 10.1038/ncomms13600.

25.

An integrated view of immune monitoring in vascularized composite allotransplantation.

Sicard A, Kanitakis J, Dubois V, Petruzzo P, Badet L, Thaunat O, Morelon E.

Curr Opin Organ Transplant. 2016 Oct;21(5):516-22. doi: 10.1097/MOT.0000000000000354. Review.

PMID:
27517506
26.

Anti-Donor HLA Antibody Response After Pancreatic Islet Grafting: Characteristics, Risk Factors, and Impact on Graft Function.

Pouliquen E, Baltzinger P, Lemle A, Chen CC, Parissiadis A, Borot S, Frimat L, Girerd S, Berney T, Lablanche S, Benhamou PY, Morelon E, Badet L, Dubois V, Kessler L, Thaunat O; GRAGIL Network.

Am J Transplant. 2017 Feb;17(2):462-473. doi: 10.1111/ajt.13936. Epub 2016 Jul 25.

27.

Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection.

Sicard A, Chen CC, Morelon E, Thaunat O.

Curr Opin Organ Transplant. 2016 Aug;21(4):368-74. doi: 10.1097/MOT.0000000000000329. Review.

PMID:
27258579
28.

Chronic Rejection in Human Vascularized Composite Allotransplantation (Hand and Face Recipients): An Update.

Kanitakis J, Petruzzo P, Badet L, Gazarian A, Thaunat O, Testelin S, Devauchelle B, Dubernard JM, Morelon E.

Transplantation. 2016 Oct;100(10):2053-61. doi: 10.1097/TP.0000000000001248. Review.

PMID:
27163543
29.

CD1d-restricted peripheral T cell lymphoma in mice and humans.

Bachy E, Urb M, Chandra S, Robinot R, Bricard G, de Bernard S, Traverse-Glehen A, Gazzo S, Blond O, Khurana A, Baseggio L, Heavican T, Ffrench M, Crispatzu G, Mondière P, Schrader A, Taillardet M, Thaunat O, Martin N, Dalle S, Le Garff-Tavernier M, Salles G, Lachuer J, Hermine O, Asnafi V, Roussel M, Lamy T, Herling M, Iqbal J, Buffat L, Marche PN, Gaulard P, Kronenberg M, Defrance T, Genestier L.

J Exp Med. 2016 May 2;213(5):841-57. doi: 10.1084/jem.20150794. Epub 2016 Apr 11.

30.

Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.

Mahendra A, Peyron I, Thaunat O, Dollinger C, Gilardin L, Sharma M, Wootla B, Rao DN, Padiolleau-Lefevre S, Boquet D, More A, Varadarajan N, Kaveri SV, Legendre C, Lacroix-Desmazes S.

J Immunol. 2016 May 15;196(10):4075-81. doi: 10.4049/jimmunol.1403005. Epub 2016 Apr 11.

31.

Transplantation: BENEFIT of belatacept: kidney transplantation moves forward.

Naesens M, Thaunat O.

Nat Rev Nephrol. 2016 May;12(5):261-2. doi: 10.1038/nrneph.2016.34. Epub 2016 Mar 30. No abstract available.

PMID:
27026349
32.

Capillary Thrombosis in the Skin: A Pathologic Hallmark of Severe/Chronic Rejection of Human Vascularized Composite Tissue Allografts?

Kanitakis J, Petruzzo P, Gazarian A, Karayannopoulou G, Buron F, Dubois V, Thaunat O, Badet L, Morelon E.

Transplantation. 2016 Apr;100(4):954-7. doi: 10.1097/TP.0000000000000882.

PMID:
27003099
33.

Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.

Thaunat O, Koenig A, Leibler C, Grimbert P.

J Am Soc Nephrol. 2016 Jul;27(7):1890-900. doi: 10.1681/ASN.2015070781. Epub 2016 Feb 12. Review.

34.

B Cells and Antibodies in Transplantation.

Koenig A, Mariat C, Mousson C, Wood KJ, Rifle G, Thaunat O.

Transplantation. 2016 Jul;100(7):1460-4. doi: 10.1097/TP.0000000000001069.

PMID:
26845305
35.

Monitoring efficiency of humoral rejection episode therapy in liver transplantation: any role for complement binding Luminex Single Antigen assays?

Ducreux S, Guillaud O, Bosch A, Thaunat O, Morelon E, Hervieu V, Mekki Y, Boillot O, Scoazec JY, Dubois V, Dumortier J.

Transpl Immunol. 2016 Mar;35:23-8. doi: 10.1016/j.trim.2016.01.007. Epub 2016 Feb 1.

PMID:
26845020
36.

Autoimmune Recurrence as a Cause of Adrenal Gland Graft Loss?

Buron F, Vouillarmet J, Thaunat O, Thivolet C, Badet L, Morelon E.

Am J Transplant. 2016 Jul;16(7):2235-6. doi: 10.1111/ajt.13737. Epub 2016 Mar 9. No abstract available.

37.

B Cells Loaded with Synthetic Particulate Antigens: A Versatile Platform To Generate Antigen-Specific Helper T Cells for Cell Therapy.

Sicard A, Koenig A, Graff-Dubois S, Dussurgey S, Rouers A, Dubois V, Blanc P, Chartoire D, Errazuriz-Cerda E, Paidassi H, Taillardet M, Morelon E, Moris A, Defrance T, Thaunat O.

Nano Lett. 2016 Jan 13;16(1):297-308. doi: 10.1021/acs.nanolett.5b03801. Epub 2015 Dec 16.

PMID:
26650819
38.

Finding the safe place between the hammer and the anvil: sounding the depth of therapeutic immunosuppression.

Thaunat O.

Kidney Int. 2015 Dec;88(6):1226-1228. doi: 10.1038/ki.2015.268.

PMID:
26649660
39.

Immunopathology of rejection: do the rules of solid organ apply to vascularized composite allotransplantation?

Thaunat O, Badet L, Dubois V, Kanitakis J, Petruzzo P, Morelon E.

Curr Opin Organ Transplant. 2015 Dec;20(6):596-601. doi: 10.1097/MOT.0000000000000242. Review.

PMID:
26536419
40.

Soothing touch of CD31 protects endothelium during cellular immune responses.

Thaunat O.

Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13133-4. doi: 10.1073/pnas.1517580112. Epub 2015 Oct 19. No abstract available.

41.

Recent advances in renal transplantation: antibody-mediated rejection takes center stage.

Pouliquen E, Koenig A, Chen CC, Sicard A, Rabeyrin M, Morelon E, Dubois V, Thaunat O.

F1000Prime Rep. 2015 May 12;7:51. doi: 10.12703/P7-51. eCollection 2015. Review.

42.

Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival.

Guidicelli G, Guerville F, Lepreux S, Wiebe C, Thaunat O, Dubois V, Visentin J, Bachelet T, Morelon E, Nickerson P, Merville P, Taupin JL, Couzi L.

J Am Soc Nephrol. 2016 Feb;27(2):615-25. doi: 10.1681/ASN.2014040326. Epub 2015 Jun 5.

43.

Clinicopathological Findings of Chronic Rejection in a Face Grafted Patient.

Petruzzo P, Kanitakis J, Testelin S, Pialat JB, Buron F, Badet L, Thaunat O, Devauchelle B, Morelon E.

Transplantation. 2015 Dec;99(12):2644-50. doi: 10.1097/TP.0000000000000765.

PMID:
25989498
44.

Cell therapy to induce allograft tolerance: time to switch to plan B?

Sicard A, Koenig A, Morelon E, Defrance T, Thaunat O.

Front Immunol. 2015 Apr 7;6:149. doi: 10.3389/fimmu.2015.00149. eCollection 2015. Review.

45.

Bridging innate with adaptive immunity in transplantation: triggers, sensors, and modulators.

Wood KJ, Mariat C, Thaunat O, Mousson C, Rifle G.

Transplantation. 2014 Nov 27;98(10):1021-4. doi: 10.1097/TP.0000000000000427.

PMID:
25286058
46.

Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.

Sicard A, Ducreux S, Rabeyrin M, Couzi L, McGregor B, Badet L, Scoazec JY, Bachelet T, Lepreux S, Visentin J, Merville P, Fremeaux-Bacchi V, Morelon E, Taupin JL, Dubois V, Thaunat O.

J Am Soc Nephrol. 2015 Feb;26(2):457-67. doi: 10.1681/ASN.2013101144. Epub 2014 Aug 14.

47.

Impact of anti-insulin antibodies on islet transplantation outcome: data from the GRAGIL Network.

Lablanche S, Borot S, Thaunat O, Bayle F, Badet L, Morelon E, Thivolet C, Wojtusciszyn A, Frimat L, Kessler L, Penfornis A, Brault C, Colin C, Bosco D, Berney T, Benhamou PY; GRAGIL Network.

Transplantation. 2014 Aug 27;98(4):475-82. doi: 10.1097/TP.0000000000000081.

PMID:
24837539
48.

Allotransplantation of kidney from unrelated living donor with loin pain haematuria syndrome.

Thaunat O, Kervella D, Matillon X, Rabeyrin M, Martin X, Morelon E, Badet L.

Transpl Int. 2014 Mar;27(3):e24-6. doi: 10.1111/tri.12245. Epub 2013 Dec 6. No abstract available.

49.

Epstein-Barr virus-associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient.

Conrad A, Brunet AS, Hervieu V, Chauvet C, Buron F, Collardeau-Frachon S, Rivet C, Cassier P, Testelin S, Lachaux A, Morelon E, Thaunat O.

Transpl Infect Dis. 2013 Oct;15(5):E182-6. doi: 10.1111/tid.12126. Epub 2013 Aug 27. Review.

PMID:
24034213
50.

IVIg treatment reduces catalytic antibody titers of renal transplanted patients.

Mahendra A, Peyron I, Dollinger C, Gilardin L, Sharma M, Wootla B, Padiolleau-Lefevre S, Friboulet A, Boquet D, Legendre C, Kaveri SV, Thaunat O, Lacroix-Desmazes S.

PLoS One. 2013 Aug 15;8(8):e70731. doi: 10.1371/journal.pone.0070731. eCollection 2013.

Supplemental Content

Loading ...
Support Center